Global Diphtheria Market - Industry Trends and Forecast to 2029

Diphtheria Market Analysis and Size

The global diphtheria market is expected to witness significant growth during the forecast period. Growing cases of airborne droplets infections and people with HIV-AIDS have high chance to get diphtheria infection which also drives the diphtheria market. The increasing use of vaccines rather than traditional vaccines are some factors that boosted the market growth . In addition, advances in the treatment options and the presence of well-established healthcare facilities are some of the impacting factors for the demand of diphtheria market. COVID-19 also had a major impact on the market growth.

Data Bridge Market Research analyses a growth rate in the global diphtheria market in the forecast period 2022-2029. The expected CAGR of global diphtheria market is tend to be around 5.50% in the mentioned forecast period. The market was valued at USD 7.8 billion in 2021, and it would grow upto USD 11.97 billion by 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Market Definition

Diphtheria is a serious bacterial infection that usually affects the mucous membrane of the throat and nose. It can spread through person to person and it can be prevented through vaccination. Once the person infected with diphtheria, the bacteria produces toxins which spread through bloodstream and often causes a thick, grey coating on infected areas. Symptoms of diphtheria include common cold, loud & barking cough, difficulty breathing & swallowing, changes in vision.  

Diphtheria Market Scope and Segmentation

Global Diphtheria Market Dynamics

Drivers

• Prevalence of Diphtheria

A total of 8,819 cases of diphtheria were witnessed worldwide in 2017. In the year 2021, between epidemiological week (EW) 1 and EW 42, four countries reported confirmed cases of diphtheria. Thus, it boosts the market growth.

• Rising Demand for Oral Drugs

Oral drugs is expected to boost the market growth. The segment is expected to accelerate the global market as most products are available in capsule and tablet form and it is a very feasible route of administration.

Opportunities

• Increasing Demand for Retail Pharmacies

The rise in the number of hepatitis E therapeutics delivered through retail pharmacies and the surge in the number of retail pharmacies in developed countries create opportunities for the market growth. In addition to this, patients prefer retail pharmacies for purchasing drugs, as these are easily accessible.

• Increased Research Development

The increasing investment in R&D activities, increasing government support for the vaccination programs, and rising awareness are boosting growth opportunities to the market. For instance, Scripps Research Florida has developed a non-traditional vaccine for fighting SIVmac29 viral strain “death star” that will provide double protection to the unaffected  individuals. In addition to this, Pan American Health Organization revolving fund and UNICEF supply divisions that allow vaccine procurement at much lower cost for several countries. This boost the market growth.

 Restraints/Challenges

• Lack of skilled professionals

The lack of qualified personnel who are unable to treat the patients with appropriate treatments could curb the growth of the global diphtheria market over a forecast period.

• High Cost

The huge expenditure associated with diphtheria treatment medications and vaccines surely hamper the market growth.

This global diphtheria market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global diphtheria market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Diphtheria Market Scope

The global diphtheria market is segmented on the basis of type, diagnosis, treatment, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

• Diphtheria
• Skin Diphtheria
• Others

Diagnosis

• Physical Examination
• Throat Culture
• Others

Treatment

• Antibiotics
• Antitoxin
• Others

Route of Administration

• Oral
• Parenteral
• Others

End User

• Hospitals
• Homecare
• Specialty Clinics
• Others

Distribution Channel

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Global Diphtheria Market Regional Analysis/Insights

The global diphtheria market is analysed and market size insights and trends are provided by type, diagnosis, treatment, route of administration, distribution channel and end-user as referenced above.

The major countries covered in the global diphtheria market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America has been witnessing a positive growth for global diphtheria market throughout the forecasted period due to increased healthcare expenditure and government focus towards providing reliable healthcare solution.

Asia-Pacific dominates the market due to rapidly improving health care infrastructure in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Diphtheria Market Share Analysis

The global diphtheria market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global diphtheria market.

Key players operating in the global diphtheria market include:

• Pfizer Inc. (U.S.)
• GlaxoSmithKline plc (U.K.)
• Novartis AG (Switzerland)
• Mylan N.V. (U.S.)
• Sanofi (France)
• Boehringer Ingelheim International GmbH. (Germany)
• Merck & Co., Inc. (U.S.)
• F. Hoffmann-La Roche Ltd. (Switzerland)
• Bristol-Myers Squibb Company (U.S.)
• Bharat Biotech (India)
• Shanghai Institute of Biological Product (China)
• Wuhan Institute of Biological Products (China)
• Chengdu Institute of Biological Products (China)

SKU-53812